The compliance challenges facing Canadian Life Sciences companies grow more complex each day. On December 12, 2017, Ontario passed legislation to strengthen transparency in health care making Ontario the first province in Canada to require the medical industry, including pharmaceutical and medical device manufacturers, to disclose payments made to health care professionals and organizations, as well as other recipients. British Columbia is looking to follow suit.
In the coming months, Canadian Life Sciences companies will need to create and implement an efficient transparency program and embed that effectively in their overall compliance program. IQVIA and Polaris have developed a Transparency Readiness Roadmap, that includes 5 critical steps that will help ensure that your organization is ready.
This webinar discusses the challenges Canadian Life Sciences companies face as well as share expert guidance, best practices and actionable steps that you can take today to ensure that you are prepared for future regulations.